Showing results (11-20 of 177) with videos related to

Sort By:
Pageof 18
Expert Review of Hematology|December 25, 2019
The role of regulatory T cells in graft-versus-host disease managementJennifer S Whangbo, Joseph H Antin, John Koreth
American Journal of Hematology|December 28, 2023
Persistent Sweet syndrome post-hematopoietic stem cell transplantation heralding molecular relapse of myelofibrosisDavid H Xiang, Mohammadreza Pakyari, John Koreth, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a reviewJohn Koreth, Edwin P Alyea, William J Murphy, et al.
Blood|January 3, 2012
Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplantKaren K Ballen, John Koreth, Yi-Bin Chen, et al.
Blood|December 2, 2006
Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantationCorey Cutler, Shuli Li, Vincent T Ho, et al.
Frontiers in Immunology|October 3, 2022
Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients with refractory chronic graft-versus-host diseaseVeronica Donato, Haesook T Kim, Peter Stowe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 14, 2009
Blood stem cell transplantation in older patientsWilliam J Murphy, Andrew S Artz, Richard E Champlin, et al.
Blood|January 20, 2007
Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantationPhilippe Armand, Haesook T Kim, Corey S Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantationVincent T Ho, Julie Aldridge, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 1, 2013
Outcome and prognostic factors for patients who relapse after allogeneic hematopoietic stem cell transplantationGita Thanarajasingam, Haesook T Kim, Corey Cutler, et al.
Pageof 18